Polynucleotides encoding NOTCH1 receptor antibodies
AssigneeOncoMed Pharmaceuticals, Inc.
InventorsAustin L. Gurney, Timothy Charles Hoey, Maureen Fitch Bruhns, Fumiko Takada Axelrod
Life of this patent
Estimating the term…
Loading patent…
AssigneeOncoMed Pharmaceuticals, Inc.
InventorsAustin L. Gurney, Timothy Charles Hoey, Maureen Fitch Bruhns, Fumiko Takada Axelrod
Estimating the term…
The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means and methods for the diagnosis, characterization, prognosis and treatment of cancer and specifically targeting cancer stem cells. The present invention provides an antibody that specifically binds to a non-ligand binding membrane proximal region of the extracellular domain of a human Notch receptor and inhibits tumor growth. The present invention further provides a method of treating cancer, the method comprising administering a therapeutically effective amount of an antibody that specifically binds to a non-ligand binding membrane proximal region of the extracellular domain of a human Notch receptor protein and inhibits tumor growth.
An isolated polynucleotide encoding an antibody that specifically binds human NOTCH1, wherein the antibody comprises:
An isolated polynucleotide encoding a polypeptide comprising the sequence of:
An isolated polynucleotide comprising the sequence of:
An isolated polynucleotide deposited with ATCC as PTA-9549.
An isolated polynucleotide encoding the hybridoma deposited with ATCC as PTA-9405.
Dependencies are inferred from the claim text.